Stool Microbiome Features and Weight Change Response to Treatment for cancer cachexia
Journal of Cachexia, Sarcopenia and Muscle · 2025-06 · 16 (3)
DOI: 10.1002/jcsm.13816 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 05.05.2025. Verfasst von Rima Nasrah und 5 weiteren Autor:innen. Beteiligte Einrichtung: McGill Cancer Nutrition Rehabilitation Program, Jewish General Hospital (CNR-JGH), Montreal, Canada. Hauptthemen laut MEDLINE: Cachexia, Feces, Neoplasms, Gastrointestinal Microbiome. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lady Davis Institute Clinical Research Pilot Project (CliPP), Jewish General Hospital, Peter Brojde Lung Cancer Centre and the Backler Foundation, Jewish General Hospital Foundation.
Abstract (Originalsprache)
Background and Aims Cancer cachexia is characterised by significant weight loss and muscle wasting that adversely affects patient outcomes. Nutritional interventions in cancer cachexia leads to improved outcomes, including improved weight change. However, there are wide variations in weight response to dietary interventions. Thus, it remains difficult to predict response to a given increase in dietary intake at an individual patient level. This study aimed to identify gut microbiome features that could serve as potential predictive biomarkers for response to individualized dietary intervention in patients with cancer cachexia attending the McGill Cancer Nutrition‐Rehabilitation Program at the Jewish General Hospital (CNR‐JGH).
Methods
Participants were recruited from CNR‐JGH clinic. Interventions included individualized nutritional counselling by a registered dietitian, to increase energy and protein intake to meet recommended levels. Stool DNA samples were collected at baseline (V1) and visit 2 (V2), and gut microbiome profiles were analysed to assess microbial diversity and identify differentially abundant genera in patients who lost weight (WL, N = 8) vs. maintained/gained weight (WSG, N = 29) at subsequent CNR‐JGH clinic visits.
Results
Greater alpha‐diversity and higher Lachnospira genus abundance at baseline predicted higher likelihood that patients would have good response to CNR‐JGH intervention (WSG at V2). Though predictors of poor response to nutritional intervention (WL at V2) were not identified, subjects in the WL group exhibited lower alpha‐diversity and greater microbial population instability after CNR‐JGH interventions.
Conclusions
In this cohort of patients with cancer‐related weight loss attending a cancer cachexia clinic, certain gut microbiome features were associated with response to dietary interventions. Patients who lost weight after CNR‐JGH intervention also developed a less diverse and less stable gut microbiome. Lachnospira genus abundance is a potential predictor of positive weight change response to dietary intervention as part of multimodal care for cancer cachexia, and further confirmatory studies are warranted. In addition, targeted dietary approaches to maintain diversity and gut microbiome population stability may have a role in improving the response to dietary interventions in cancer cachexia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- McGill Cancer Nutrition Rehabilitation Program, Jewish General Hospital (CNR-JGH), Montreal, Canada.
- Peter Brojde Lung Cancer Centre, Segal Cancer Centre, Jewish General Hospital, Montreal, Canada.
- Division of Experimental Medicine, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada.
- McGill Centre for Microbiome Research, McGill University, Montreal, QC, Canada.
- Department of Human Genetics, McGill University, Montreal, QC, Canada.
- Research Institute of the McGill University Health Centre, Montréal, QC, Canada.
ORCID-Profile: Rima Nasrah
Förderung
- Lady Davis Institute Clinical Research Pilot Project (CliPP), Jewish General Hospital
- Peter Brojde Lung Cancer Centre and the Backler Foundation, Jewish General Hospital Foundation
Zitieren
APA
Nasrah, R., Kanbalian, M., Van Der Borch, C., Dewar, K., Chevalier, S., & Jagoe, R. T. (2025). Stool Microbiome Features and Weight Change Response to Treatment for cancer cachexia. Journal of Cachexia, Sarcopenia and Muscle, 16(3). https://doi.org/10.1002/jcsm.13816
Vancouver
Nasrah R, Kanbalian M, Van Der Borch C, Dewar K, Chevalier S, Jagoe RT. Stool Microbiome Features and Weight Change Response to Treatment for cancer cachexia. Journal of Cachexia, Sarcopenia and Muscle. 2025;16(3). doi:10.1002/jcsm.13816
BibTeX
@article{Nasrah2025,
author = {Nasrah, Rima and Kanbalian, Mary and Van Der Borch, Christina and Dewar, Ken and Chevalier, Stéphanie and Jagoe, R Thomas},
title = {Stool Microbiome Features and Weight Change Response to Treatment for cancer cachexia},
journal = {Journal of Cachexia, Sarcopenia and Muscle},
year = {2025},
volume = {16},
number = {3},
doi = {10.1002/jcsm.13816}
}
EUVIMED